Home › Funds › TENOR CAPITAL MANAGEMENT Co., L.P. › MIRM

TENOR CAPITAL MANAGEMENT Co., L.P. position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

TENOR CAPITAL MANAGEMENT Co., L.P. reported holding 24,653,000 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$91.7M, representing 1.70% of its reported portfolio and ranking #9 among its reported holdings. TENOR CAPITAL MANAGEMENT Co., L.P. has disclosed MIRM holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)24.65M sh
Reported value held$91.66M
Portfolio Weight1.70%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TENOR CAPITAL MANAGEMENT Co., L.P.'s MIRM position evolved

TENOR CAPITAL MANAGEMENT Co., L.P. first disclosed a stake in MIRM in Q3 2025 at 25,165,000 shares (US$61.0M). The position peaked in Q1 2026 at 43,792,000 shares, worth US$131.7M. Across 4 filings, TENOR CAPITAL MANAGEMENT Co., L.P. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 24,653,000 shares valued at US$91.7M — a reduction of -19,139,000 shares quarter over quarter.. Notable position changes include a 53% increase in Q1 2026 (shares rose 27% over the following quarter), a 44% trim in Q2 2026 (shares fell 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 25.16M $61.03M New
Q4 2025 28.58M $74.20M Add
Q1 2026 43.79M $131.68M Add
Q2 2026 24.65M $91.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 61 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has TENOR CAPITAL MANAGEMENT Co., L.P. held MIRM?

TENOR CAPITAL MANAGEMENT Co., L.P. has disclosed MIRM holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is TENOR CAPITAL MANAGEMENT Co., L.P.'s current position in MIRM?

As of Q2 2026, TENOR CAPITAL MANAGEMENT Co., L.P. holds 24.65M shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $91.66M, representing 1.70% of its reported portfolio and ranking #9.

Has TENOR CAPITAL MANAGEMENT Co., L.P. been buying or selling MIRM?

In the latest 13F filing (Q2 2026), TENOR CAPITAL MANAGEMENT Co., L.P. reduced its position in MIRM. The position peaked in Q1 2026 at 43.79M shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.